Advertisement

Drugs for the Treatment of Parkinson’s Disease

  • Donald B. Calne

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 88)

Table of contents

  1. Front Matter
    Pages I-XXIV
  2. W. Schultz
    Pages 1-45
  3. K. Jellinger
    Pages 47-112
  4. E. G. McGeer, P. L. McGeer
    Pages 113-148
  5. A. B. Young, J. B. Penney
    Pages 149-163
  6. W. R. W. Martin
    Pages 165-183
  7. J. W. Langston, I. Irwin
    Pages 205-226
  8. H. Teräväinen, J. Tsui, D. B. Calne
    Pages 271-279
  9. J. K. Tsui, H. Teräväinen, D. B. Calne
    Pages 281-288
  10. M. Sandler, V. Glover
    Pages 411-431
  11. M. D. Yahr, H. Kaufmann
    Pages 433-441
  12. A. N. Lieberman, M. Goldstein
    Pages 443-458
  13. C. H. Markham, S. G. Diamond
    Pages 459-470
  14. G. Gopinathan, R. Horowski, I. H. Suchy
    Pages 471-513
  15. J. D. Parkes
    Pages 515-530
  16. J. A. Obeso, S. M. Stahl
    Pages 531-541
  17. H. L. Klawans, C. M. Tanner
    Pages 557-571
  18. Back Matter
    Pages 587-599

About this book

Keywords

Parkinson adverse reactions anatomy antioxidant dopamine pharmacology physiology

Editors and affiliations

  • Donald B. Calne
    • 1
  1. 1.Division of NeurologyUBC Health Sciences Centre HospitalVancouverCanada

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-73899-9
  • Copyright Information Springer-Verlag Berlin Heidelberg 1989
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-73901-9
  • Online ISBN 978-3-642-73899-9
  • Series Print ISSN 0171-2004
  • Series Online ISSN 1865-0325
  • Buy this book on publisher's site